Ryan Johnson,Paul H McClelland,Syed A Ahmad
Ryan Johnson
While pancreatic adenocarcinoma requires surgical resection definitive cure, treatment paradigms are shifting toward a neoadjuvant approach to systemic therapy. Rationale is twofold: micro-metastatic disease is likely present in a majority ...
Use of Diagnostic Laparoscopy and Peritoneal Washings for Pancreatic Cancer [0.03%]
诊断性腹腔镜和腹膜冲洗在胰腺癌中的应用
Samantha M Ruff,Susan Tsai
Samantha M Ruff
Pancreatic adenocarcinoma is an aggressive malignancy that often presents with advanced disease. Accurate staging is essential for treatment planning and shared decision-making with patients. Staging laparoscopy is a minimally invasive proc...
Tommaso Pollini,Letizia Todeschini,Ajay V Maker
Tommaso Pollini
Pancreatic Cystic Neoplasms (PCN) represent a diverse group of tumors, some of which may progress to pancreatic cancer. Considering their high prevalence in the general population, the development of reliable biomarkers is crucial. The idea...
Kevin M Turner,Sameer H Patel
Kevin M Turner
Pancreatic ductal adenocarcinoma (PDAC) continues to remain one of the leading causes of cancer-related death. Unlike other malignancies where universal screening is recommended, the same cannot be said for PDAC. The purpose of this study i...
Jaewon James Lee,Jen Jen Yeh
Jaewon James Lee
Outcomes from pancreatic ductal adenocarcinoma (PDAC) remain poor and better methods of prognostication and therapeutic approaches are needed. Recent advances in cancer genomics have led to the development of molecular subtypes of PDAC asso...
Caitlin S Jacobs,Dominic J Vitello,Akhil Chawla
Caitlin S Jacobs
To provide optimal care in pancreatic ductal adenocarcinoma, involvement of palliative medicine and nutritional support is recommended. Advances in endoscopy have resulted in robust options for biliary and gastrointestinal stenting for reli...
The Grade C Pancreatic Fistula [0.03%]
C级胰瘘
Stephen W Behrman
Stephen W Behrman
Grade C pancreatic fistulas are associated with severe morbidity and a significant risk of mortality. High-risk pancreatic anastomoses can be predicted to allow best practice fistula mitigation techniques. In these high-risk glands, any dev...
Alexandra W Acher,Julie Hallet
Alexandra W Acher
This article presents updates in the surgical management of non-functional sporadic pancreas neuroendocrine tumors NET, including considerations for assessment of biologic behavior to support decision-making, indications for surgery, and su...
Hussein M Hariri,Samuel B Perez,Kevin M Turner et al.
Hussein M Hariri et al.
Minimally invasive procedures minimize trauma to the human body while maintaining satisfactory therapeutic results. Minimally invasive pancreas surgery (MIPS) was introduced in 1994, but questions regarding its efficacy compared to an open ...
D Brock Hewitt,Christopher L Wolfgang
D Brock Hewitt
The majority of patients diagnosed with pancreatic cancer already have metastatic disease at the time of presentation, which results in a 5-year survival rate of only 13%. However, multiagent chemotherapy regimens can stabilize the disease ...